FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023737387> ?p ?o ?g. }

• W2023737387 endingPage "43" @default.
• W2023737387 startingPage "37" @default.
• W2023737387 abstract "To report the efficacy of catheter-directed thrombolysis with a combination of a thrombolytic agent (reteplase) and a glycoprotein (GP) IIb/IIIa platelet receptor antagonist (abciximab) in peripheral arterial occlusive disease.Fifteen patients with lower extremity arterial thromboses (age range, 40-96 y; mean, 73 y) were prospectively enrolled in a protocol approved by the Institutional Review Committee. Nine patients had native arterial occlusions, three (33%) of whom had subacute symptoms (>14 d) and one of whom had chronic symptoms (>3 mo). Four patients had acute arterial graft thromboses. Two patients with lower extremity bypass grafts presented with subacute limb ischemia. All patients received catheter-directed infusion of reteplase (0.5 U/h) in combination with intravenous administration of abciximab (0.25-mg/kg bolus followed by 0.125 microg/kg/min infusion) for 12 hours without systemic heparinization. The thrombolytic success was studied by Doppler ultrasonography (US) and angiography.Complete thrombolysis and clinical success was achieved in 14 of the 15 patients (93%). One patient with unsuccessful thrombolysis underwent major amputation. The mean thrombolysis time per Doppler US procedure was 6.8 hours (range, 2-30 h). Angiographic patency was achieved at a mean of 17.5 hours (range, 4-36 h) corresponding to a mean dose of reteplase of 8.8 U. The mean increase in ankle-brachial index was 0.52 (range, 0-0.9). No major hemorrhagic complications occurred. The 30-day primary patency rate was 93%.The combination of reteplase and abciximab in catheter-directed arterial thrombolysis is feasible and effective. This combination therapy pilot study suggests short thrombolysis times and minimal adverse effects in catheter-directed thrombolytic therapy for peripheral arterial occlusive disease." @default.
• W2023737387 created "2016-06-24" @default.
• W2023737387 creator A5006497777 @default.
• W2023737387 creator A5019396332 @default.
• W2023737387 creator A5040803639 @default.
• W2023737387 date "2002-01-01" @default.
• W2023737387 modified "2023-09-27" @default.
• W2023737387 title "Initial Experience with the Combination of Reteplase and Abciximab for Thrombolytic Therapy in Peripheral Arterial Occlusive Disease: A Pilot Study" @default.
• W2023737387 cites W1967919536 @default.
• W2023737387 cites W1976173009 @default.
• W2023737387 cites W1990381194 @default.
• W2023737387 cites W1994674815 @default.
• W2023737387 cites W1994685505 @default.
• W2023737387 cites W2011455230 @default.
• W2023737387 cites W2012878236 @default.
• W2023737387 cites W2020608402 @default.
• W2023737387 cites W2022108827 @default.
• W2023737387 cites W2041147369 @default.
• W2023737387 cites W2043517681 @default.
• W2023737387 cites W2058243324 @default.
• W2023737387 cites W2058275250 @default.
• W2023737387 cites W2059039823 @default.
• W2023737387 cites W2064263411 @default.
• W2023737387 cites W2067277409 @default.
• W2023737387 cites W2072497476 @default.
• W2023737387 cites W2079803957 @default.
• W2023737387 cites W2088772142 @default.
• W2023737387 cites W2096468159 @default.
• W2023737387 cites W2104561779 @default.
• W2023737387 cites W2119396179 @default.
• W2023737387 cites W2164128750 @default.
• W2023737387 cites W2165843643 @default.
• W2023737387 cites W2325910649 @default.
• W2023737387 cites W2342256744 @default.
• W2023737387 cites W2413086606 @default.
• W2023737387 cites W2469237359 @default.
• W2023737387 cites W4211187921 @default.
• W2023737387 cites W4231815458 @default.
• W2023737387 cites W4234638057 @default.
• W2023737387 cites W4249458268 @default.
• W2023737387 doi "https://doi.org/10.1016/s1051-0443(07)60006-2" @default.
• W2023737387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11788692" @default.
• W2023737387 hasPublicationYear "2002" @default.
• W2023737387 type Work @default.
• W2023737387 sameAs 2023737387 @default.
• W2023737387 citedByCount "27" @default.
• W2023737387 countsByYear W20237373872012 @default.
• W2023737387 countsByYear W20237373872013 @default.
• W2023737387 countsByYear W20237373872017 @default.
• W2023737387 countsByYear W20237373872020 @default.
• W2023737387 crossrefType "journal-article" @default.
• W2023737387 hasAuthorship W2023737387A5006497777 @default.
• W2023737387 hasAuthorship W2023737387A5019396332 @default.
• W2023737387 hasAuthorship W2023737387A5040803639 @default.
• W2023737387 hasConcept C126322002 @default.
• W2023737387 hasConcept C141071460 @default.
• W2023737387 hasConcept C2776336681 @default.
• W2023737387 hasConcept C2776572282 @default.
• W2023737387 hasConcept C2776892390 @default.
• W2023737387 hasConcept C2777871224 @default.
• W2023737387 hasConcept C2779581417 @default.
• W2023737387 hasConcept C2780790693 @default.
• W2023737387 hasConcept C2781267111 @default.
• W2023737387 hasConcept C2909817843 @default.
• W2023737387 hasConcept C42219234 @default.
• W2023737387 hasConcept C43376680 @default.
• W2023737387 hasConcept C45393284 @default.
• W2023737387 hasConcept C500558357 @default.
• W2023737387 hasConcept C71924100 @default.
• W2023737387 hasConceptScore W2023737387C126322002 @default.
• W2023737387 hasConceptScore W2023737387C141071460 @default.
• W2023737387 hasConceptScore W2023737387C2776336681 @default.
• W2023737387 hasConceptScore W2023737387C2776572282 @default.
• W2023737387 hasConceptScore W2023737387C2776892390 @default.
• W2023737387 hasConceptScore W2023737387C2777871224 @default.
• W2023737387 hasConceptScore W2023737387C2779581417 @default.
• W2023737387 hasConceptScore W2023737387C2780790693 @default.
• W2023737387 hasConceptScore W2023737387C2781267111 @default.
• W2023737387 hasConceptScore W2023737387C2909817843 @default.
• W2023737387 hasConceptScore W2023737387C42219234 @default.
• W2023737387 hasConceptScore W2023737387C43376680 @default.
• W2023737387 hasConceptScore W2023737387C45393284 @default.
• W2023737387 hasConceptScore W2023737387C500558357 @default.
• W2023737387 hasConceptScore W2023737387C71924100 @default.
• W2023737387 hasIssue "1" @default.
• W2023737387 hasLocation W20237373871 @default.
• W2023737387 hasLocation W20237373872 @default.
• W2023737387 hasOpenAccess W2023737387 @default.
• W2023737387 hasPrimaryLocation W20237373871 @default.
• W2023737387 hasRelatedWork W110994545 @default.
• W2023737387 hasRelatedWork W2000353162 @default.
• W2023737387 hasRelatedWork W2023737387 @default.
• W2023737387 hasRelatedWork W2047829215 @default.
• W2023737387 hasRelatedWork W2090952370 @default.
• W2023737387 hasRelatedWork W2097359738 @default.
• W2023737387 hasRelatedWork W2150296762 @default.
• W2023737387 hasRelatedWork W2416316301 @default.
• W2023737387 hasRelatedWork W2951896368 @default.

• next